Поиск
Закладки
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.
Пневмония (внебольничная)

Список литературы

  1. Геппе Н. А., Розинова Н. Н., Волков И. К., Мизерницкий Ю. Л. Рабочая классификация основных клинических форм бронхолегочных заболеваний у детей // ПМ. 2010. №45.
  2. Bradley JS, Byington CL, Shah SS, et al. Executive summary: the management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America., Clin Infect Dis, № 53(7), pp. 617-30, Oct 2011.
  3. Pocket book of hospital care for children: Second edition: Guidelines for the management of common childhood illnesses. WHO, 2013.
  4. Российское респираторное общество; Межрегиональное педиатрическое респираторное общество; Федерация педиатров стран СНГ; Московское общество детских врачей. Внебольничная пневмония у детей. Клинические рекомендации. М.: Оригинал-макет; 2015. 64 с.
  5. Michelow IC, Olsen K, Lozano J, et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics. 2004 Apr. 113(4):701-7.
  6. Jain S, et al; CDC EPIC Study Team. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med. 2015;372(9):835-45
  7. Yun KW, et al. Community-Acquired Pneumonia in Children: Myths and Facts. Am J Perinatol. 2019; 36(S02):S54-S57
  8. Kaz SE, Wiliams D. Pediatric community- acquired pneumonia in the United States: changing epidemiology, diagnostic and therapeutic challenges, and areas for future research. Infect Dis Clin North Am. 2018;32(1):47-63
  9. Gareca Perales J., Soleto Ortiz. Diagnosis of Community-acquired Pneumonia in Hospitalized Children. A Multicenter Experience in Bolivia. PIDJ: 2020; 10.1097/ INF.0000000000002909.
  10. Rhedin S; Lindstrand A; HjelmgrenA. respiratory viruses associated with community- acquired pneumonia in children. Matched Case-Control study. Thorax 2015; 70(9):847- 853.
  11. Таточенко В. К. (ред). Острые пневмонии у детей. Чебоксары, 1994, 323 с..
  12. Prit B.S., M.Ch. Aubry. Histopathology of viral infections of the lung. Semin Diagn Pathol. 2017; 34(6): 510–517.
  13. Самсонова М.В. Черняев А.Л. Михалева Л.М. с соавт. Патологическая анатомия легких при СOVID-19. http://www.patolog.ru/sites/default/files/mv_samsonova_covid-19.
  14. Stoll BJ, Hansen NI, Higgins RD, et al. Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002-2003, Pediatr Infect Dis J., № 24(7), pp. 635-9, Jul 2005.
  15. Mishaan AM, Mason EO Jr, Martinez-Aguilar G., et al. Emergence of a predominant clone of community-acquired Staphylococcus aureus among children in Houston, Texas. Pediatr Infect Dis J. 2005 Mar. 24(3):201-6.
  16. Global Health Observatory. Proportions of child death by cause. (http://www.who.int/gho/child_health/en/index.html), WHO, Geneva Accessed on 24 July 2014.
  17. Kucova P, Kantor L, Fiserova K, Lasak J, Röderova M, Kolar M. Bacterial Pathogens and Evaluation of a Cut-Off for Defining Early and Late Neonatal Infection. Antibiotics (Basel). 2021 Mar 9;10(3):278. doi: 10.3390/antibiotics10030278]
  18. Nascimento-Carvalho CM, Ribeiro CT, Cardoso MR, Barral A, et al. The role of respiratory viral infections among children hospitalized for community-acquired pneumonia in a developing country. Pediatr Infect Dis J. 2008 Oct. 27(10):939-41.
  19. American Academy of Pediatrics Committee on Infectious Diseases. Recommended childhood and adolescent immunization schedules--United States, 2009. Pediatrics. 2009 Jan. 123(1):189-90.
  20. Tsolia MN, Psarras S, Bossios A, Audi H, Paldanius M, Gourgiotis D, et al. Etiology of community-acquired pneumonia in hospitalized school-age children: evidence for high prevalence of viral infections. Clin Infect Dis. 2004 Sep 1. 39(5):681-6.
  21. Tajima T, Nakayama E, Kondo Y, Hirai F, Ito H, Iitsuka T, et al. Etiology and clinical study of community-acquired pneumonia in 157 hospitalized children. J Infect Chemother. 2006 Dec. 12(6):372-9.
  22. Marangu D, Zar HJ. Childhood pneumonia in low-and-middle-income countries: An update. Paediatr Respir Rev. 2019 Nov;32:3-9. doi: 10.1016/j.prrv.2019.06.001
  23. Esposito S, ae. CAP in children. European respiratory monograph 63: Community-acquired pneumonia. Eds. Chalmers J, Pletz M, Aliberti S. 2014. p. 130–139
  24. Кузьменков А.Ю., Трушин И.В., Авраменко А.А., с соавт. AMRmap: Интернет- платформа мониторинга антибиотикорезистентности. Клин Микробиол Антимикроб Химиотер. 2017; 19 (2): 84-90.
  25. Баранов А.А., Намазова Л.С., Таточенко В.К. Пневмококковая инфекция и связанные с ней заболевания – серьезная проблема современного здравоохранения. Педиатрическая фармакология. 2008; 5 (1): 7-12
  26. Козлов Р.С., Синопальников А.И., Зайцева О.В., и др. Ингибиторозащищенный амоксициллин с повышенным содержанием амоксициллина и соотношением действующих компонентов 14:1: место в лечении внебольничных инфекций дыхательных путей и ЛОР-органов у детей Резолюция Экспертного совета. Клинический разбор в общей медицине. 2021; 2: 6–14. DOI: 10.47407/kr2021.2.1.00036
  27. Torumkuney D., Mayanskiy N., Edelstein M., et al. Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Russia. J Antimicrob Chemother. 2018; 73(suppl_5): v14- v21. DOI:10.1093/jac/dky065
  28. Иванова О.В., Эйдельштейн И.А., Ромашов О.И., Козлов Р.С. Оценка влияния мутаций в гене 23S рРНК Mycoplasma pneumoniae, обуславливающих устойчивость к макролидам, на тяжесть течения внебольничной пневмонии у лиц молодого возраста, находившихся на лечении в Смоленском военном госпитале. Клиническая микробиология и антимикробная химиотерапия. 2020; 22(4):306-312. DOI: 10.36488/cmac.2020.4.306-312
  29. Анализ распространенности мутаций резистентности к макролидам и фторхинолонам у Mycoplasma genitalium и Mycoplasma pneumoniae. Available at: https://app.amrcloud.net/rus/?id=demares&public=T
  30. Rudan I, Tomaskovic L, Boschi-Pinto C, Campbell H. Global estimate of the incidence of clinical pneumonia among children under five years of age. Bull World Health Organ. 2004 Dec. 82(12):895-903.
  31. Заболеваемость населения России в 2000-2009 гг. Статистические материалы МЗСР РФ.
  32. Козлов Р.С., Кречикова О.И., Муравьев А.А. и др. Результаты исследования распространенности в России внебольничной пневмонии и острого среднего отита у детей в возрасте до 5 лет (Papirus)., «Роль S. pneumoniae и H. influenzae в этиологии данных заболеваний. Клиническая микробиология и антимикробная химиотерапия, 2013. 15 (4), 246-260».
  33. Community acquired pneumonia in children: update 2011. British Thoracic Society. Community acquired pneumonia in children guideline group. Thorax 2011;66. Suppl.2; 927-928.
  34. Levels and trends in child mortality: Report 2014. United Nations Inter Agency Group for Child Mortality Estimation. UNICEF, WHO, The World Bank, United Nations Population Divisoin. New York, 2014.
  35. Revised WHO classification and treatment of childhood pneumonia at health faciclities: evidence summaries. WHO, 2014. http://www.who.int/maternal_child_adolescent.
  36. Wingerter SL, Bachur RG, Monuteaux MC, Neuman MI. Application of the World Health Organization criteria to predict radiographic pneumonia in a US-based pediatric emergency department. Pediatr Infect Dis J. 2012 Jun. 31(6):561-4.
  37. Таточенко В.К. Болезни органов дыхания у детей. 7 изд.. М. Боргес 2019: 300 стр
  38. Rambaud-Althaus C., Althaus F., Genton B., D’Acremont V. Clinical features for diagnosis of pneumonia in children younger than 5 years: a systematic review and meta-analysis. Lancet Infect Dis 2015 Published Online March 11, 2015.
  39. Ginsburg AS, Lenahan JL, Izadnegahdar R, Ansermino JM. A Systematic Review of Tools to Measure Respiratory Rate in Order to Identify Childhood Pneumonia. Am J Respir Crit Care Med. 2018 May 1;197(9):1116-1127
  40. Boyd K. Back to the Basics: Community-Acquired Pneumonia in Children. Pediatr Ann. 2017;46(7):e257-e261.
  41. Søndergaard MJ, ea. Clinical manifestations in infants and children with Mycoplasma pneumoniae infection. PLoS One. 2018;13(4):e0195288
  42. Манеров Ф. К. Диагностика и терапия острой пневмонии у детей при разных вариантах течения. Дис. … д. м. н. Новокузнецк, 1990.
  43. Таточенко В.К. Внебольничные пневмонии у детей – проблемы и решения. Российский вестник перинатологии и педиатрии. 2021;66(1):9-21.
  44. Mcintosh K. Community-Acquired pneumonia in children // N Engl J Med. 2002; 346 (6): 429–437.
  45. Crawford S. E., Daum R. S. Bacterial pneumonia, lung abscess and empyema / Pediatric respiratory medicine / ed. Taussig L. M., Landau L. I. Mosby, Inc., 2008: 501–553.
  46. Баранов А.А. Таточенко В.К., Бакрадзе М.Д. (ред). Лихорадящий ребенок. ПедиатрЪ. 2017
  47. Goodman D, Crocker ME, Pervaiz F. Challenges in the diagnosis of paediatric pneumonia in intervention field trials: recommendations from a pneumonia field trial working group. Lancet Respir Med. 2019 Dec;7(12):1068-1083
  48. Thomas J, Pociute A, Kevalas R, Malinauskas M, Jankauskaite L. Blood biomarkers differentiating viral versus bacterial pneumonia aetiology: a literature review. Ital J Pediatr. 2020 Jan 9;46(1):4..
  49. Harris M, Clark J, Coote N, Fletcher P, Harnden A, McKean M, Thomson A; British Thoracic Society Standards of Care Committee. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax. 2011 Oct.
  50. Community acquired pneumonia in children: update 2011. British Thoracic Society. Community acquired pneumonia in children guideline group. Thorax 2011;66. Suppl.2; 927-928
  51. Bhuiyan MU, Blyth CC, West R. Combination of clinical symptoms and blood biomarkers can improve discrimination between between bacterial or viral community-acquired pneumonia in children. BMC Pulm Med. 2019 Apr 2;19(1):71.
  52. Iroh Tam PY, Bernstein E, Ma X, Ferrieri P. Blood Culture in Evaluation of Pediatric Community-Acquired Pneumonia: A Systematic Review and Meta-analysis. Hosp Pediatr. 2015 Jun;5(6):324-36..
  53. Eber E, Midulla F, eds. ERS handbook of paediatric respiratory medicine. Sheffield: European Respiratory Society, 2013: 719 p.
  54. Hosseini SM, Poorolajal J, Karami M, Ameri P. Prevalence of Nasopharyngeal Carriage of Streptococcus pneumonia in Iran: A Meta-Analysis. J Res Health Sci. 2015 Summer;15(3):141-6..
  55. Johnson HL, Deloria-Knoll M, Levine OS, Stoszek SK, Freimanis Hance L, Reithinger R, et al. Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. PLoS Med. 2010;7(10).
  56. Fernando M de Benedictis FM, Kerem E, Chang AB, Colin AA, Zar HJ, Bush A. Complicated pneumonia in children. Lancet. 2020 Sep 12;396(10253):786-798. doi: 10.1016/S0140- 6736(20)31550-6. PMID: 32919518.
  57. Временные методические рекомендации. Версия 11 от 07.05.2021. Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19).
  58. Методические рекомендации. Версия 2 от 03.07.2021. Особенности клинических проявлений и лечения заболевания, вызванного новой коронавирусной инфекцией (COVID-19) у детей.
  59. Яцышина С.Б., Спичак Т.В., Ким С.С., и др. Выявление респираторных вирусов и атипичных бактерий у больных пневмонией и здоровых детей за десятилетний период наблюдения. Журнал педиатрии им. Сперанского, 2016, т. 95, №2, с. 43-50.
  60. Spuesens EB, Fraaij PL, Visser EG, et al. Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study. PLoS Med. 2013; 10: e1001444.
  61. Copete, A.R., Vera, C., Herrera, M. et al. Mycoplasma pneumoniae in children with and without community-acquired pneumonia. What do PCR and serology say? PIDJ 2020; 39 (7): E104-E108.
  62. Guiso N, Berbers G, Fry NK, He Q, Riffelmann M, Wirsing von König CH. What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. Eur J Clin Microbiol Infect Dis. 2011 Mar;30(3):307-12.
  63. Dean P, Florin TA. Factors Associated With Pneumonia Severity in Children: A Systematic Review. J Pediatric Infect Dis Soc. 2018 Dec 3;7(4):323-334.
  64. Andronikou S, Lambert E, Halton J, Hilder L, Crumley I, Lyttle MD, Kosack C. Guidelines for the use of chest radiographs in community-acquired pneumonia in children and adolescents. Pediatr Radiol. 2017 Oct;47(11):1405-1411.
  65. Le Roux DM, Zar HJ. Community-acquired pneumonia in children - a changing spectrum of disease. Pediatr Radiol. 2017 Oct;47(11):1392-1398. doi: 10.1007/s00247-017-3827-8 37, 38.
  66. Levinsky Y, Mimouni FB, Fisher D, Ehrlichman M (2013) Chest radiography of acute paediatric lower respiratory infections: experience versus interobserver variation. Acta Paediatr 102:e310–e314.
  67. Nascimento-Carvalho CM, Araújo-Neto CA, Ruuskanen O. Association between bacterial infection and radiologically confirmed pneumonia among children. Pediatr Infect Dis J. 2015 May;34(5):490-3..
  68. Novack V, Avnon LS, Smolyakov A, et al. Disagreement in the interpretation of chest radiographs among specialists and clinical outcomes of patients hospitalized with suspected pneumonia. EurJ Intern Med 2006; 17:43–7..
  69. Johnson J, Kline JA. Intraobserver and interobserver agreement of the interpretation of pediatric chest radiographs. Emerg Radiol. 2010 Jul;17(4):285-90..
  70. Weigl J. Community acquired pneumonia in Germany. 21th Ann.Meeting of ESPID, Taormina, Sicily, April 9-12, 2003, abstr.47:p.24.
  71. Orso D, Ban A, Guglielmo N. Lung ultrasound in diagnosing pneumonia in childhood: a systematic review and meta-analysis. J Ultrasound. 2018 Sep;21(3):183-195.
  72. El Fahimi N, Calleja MA, Ratnayake L, Ali I. Audit of a multidisciplinary approach to improve management of community-acquired pneumonia. Eur J Hosp Pharm. 2019 Jul;26(4):223-225.
  73. Lodha R, Kabra SK, Pandey RM. Antibiotics for community-acquired pneumonia in children. Cochrane Database Syst Rev. 2013 Jun 4;2013(6):CD004874.
  74. Infants and Children: Acute Management of Community Acquired Pneumonia – NSW Health – Guideline – March 2018 .
  75. https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=07dd4bbb-c57c-4061-b8a9- f242cbc37cd0&t= амоксициллин АВВА-Рус
  76. https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=74b4f18a-88eb-46b5-b39c- b08e7d5bc51b&t=
  77. Козлов Р.С., Синопальников А.И., Зайцева О.В., и др. Ингибиторозащищенный амоксициллин с повышенным содержанием амоксициллина и соотношением действующих компонентов 14:1: место в лечении внебольничных инфекций дыхательных путей и ЛОР-органов у детей. Резолюция Экспертного совета. Клинический разбор в общей медицине. 2021; 2: 6–14. DOI: 10.47407/kr2021.2.1.00036
  78. Aurangzeb B., Hameed A. Comparative efficacy of amoxicillin, cefuroxime and clarithromycin in the treatment of community-acquired pneumonia in children //Journal of the College of Physicians and Surgeons--pakistan: JCPSP. – 2003. – Т. 13. – №. 12. – С. 704-707.
  79. Wubbel L. et al. Etiology and treatment of community-acquired pneumonia in ambulatory children //The Pediatric infectious disease journal. – 1999. – Т. 18. – №. 2. – С. 98-104.
  80. Schönwald S. et al. Comparison of azithromycin and erythromycin in the treatment of atypical pneumonias //Journal of antimicrobial Chemotherapy. – 1990. – Т. 25. – № . suppl_A. – С. 123-126.
  81. Ушкалова Е. А. Применение доксициклина у детей и подростков //Фарматека. – 2005. – №. 15. – С. 18.
  82. Chiappini E., et al. Rational use of antibiotics for the management of children"s respiratory tract infections in the ambulatory setting: an evidence-based consensus by the Italian Society of Preventive and Social Pediatrics. Paediatr Respir Rev. 2014; 15(3): 231-6.
  83. Mathur S, Fuchs A, Bielicki J, Van Den Anker J, Sharland M. Antibiotic use for community- acquired pneumonia in neonates and children: WHO evidence review. Paediatr Int Child Health. 2018 Nov;38(sup1):S66-S75. doi: 10.1080/20469047.2017.1409455.
  84. Matsubara K, Morozumi M, Okada T, et al. A comparative clinical study of macrolide- sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients. J Infect Chemother 2009; 15:380–3..
  85. Lee H, Yun KW, Lee HJ, Choi EH. Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. Expert Rev Anti Infect Ther. 2018 Jan;16(1):23-34.
  86. Leung AKC, Wong AHC, Hon KL. Community-Acquired Pneumonia in Children. Recent Pat Inflamm Allergy Drug Discov. 2018;12(2):136–144
  87. https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=f2820d7f-d953-41bc-a84a- 490dcadc1338&t=-
  88. Haider BA, Saeed MA, Bhutta ZA. Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in children aged 2 months to 59 months. Cochrane Database of Systematic Reviews. 2008; CD:005976.
  89. https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=b8de788e-4649-4cb2-a659- 4d7ea524a9ca&t=
  90. Cannavino CR, Nemeth A, Korczowski B, Bradley JS, O"Neal T, Jandourek A, Friedland HD, Kaplan SL. A Randomized, Prospective Study of Pediatric Patients With Community- acquired Pneumonia Treated With Ceftaroline Versus Ceftriaxone. Pediatr Infect Dis J. 2016 Jul;35(7):752-9. doi: 10.1097/INF.0000000000001159
  91. Pneumonia (community-acquired): antimicrobial prescribing NICE guideline [NG138]Published date: September 2019 https://www.nice.org.uk/guidance/ng138, Nascimento-Carvalho CM. Community-acquired pneumonia among children: the latest evidence for an updated management. J Pediatr (Rio J). 2020 Mar-Apr;96 Suppl 1:29-38.
  92. Pernica J. M., Harman S., Kam A.J. et al. Short-course antimicrobial therapy for pediatric community-acquired pneumonia. The SAFER randomized clinical trial. JAMA Pediatr. Published online March 8, 2021.
  93. Same RG, Amoah J, Hsu AJ, Hersh AL, Sklansky DJ, Cosgrove SE, Tamma PD. The Association of Antibiotic Duration With Successful Treatment of Community-Acquired Pneumonia in Children. J Pediatric Infect Dis Soc. 2021 Apr 3;10(3):267-273. doi: 10.1093/jpids/piaa055.
  94. Blaschke AJ, Heyrend C, Byington CL, et al. Molecular analysis imroves pathogen identification and epidemiologic study of pediatric parapneumonic empyema. Pediatr Infect Dis J 2011; 30:289–94.
  95. Bradley JS, Ching DK, Hart CL. Invasive bacterial disease in childhood: efficacy of oral antibiotic therapy following short course parenteral therapy in non-central nervous system infections. Pediatr Infect Dis J 1987; 6:821–5.
  96. Moreno-Pérez D, Andrés Martín A, Tagarro García A, Escribano Montaner A, Figuerola Mulet J, García García JJ, Moreno-Galdó A, Rodrigo Gonzalo de Lliria C, Saavedra Lozano J. Neumonía adquirida en la comunidad: tratamiento de los casos complicados y en situaciones especiales. Documento de consenso de la Sociedad Española de Infectología Pediátrica (SEIP) y Sociedad Española de Neumología Pediátrica (SENP) [Community acquired pneumonia in children: Treatment of complicated cases and risk patients. Consensus statement by the Spanish Society of Paediatric Infectious Diseases (SEIP) and the Spanish Society of Paediatric Chest Diseases (SENP)]. An Pediatr (Barc). 2015 Sep;83(3):217.e1-11. Spanish
  97. Jefferson T, Jones MA, Doshi P, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev. 2014; 4:CD008965.
  98. Heneghan CJ, Onakpoya I, Jones MA, Doshi P, Del Mar CB, Hama R, Thompson MJ, Spencer EA, Mahtani KR, Nunan D, Howick J, Jefferson T. Neuraminidase inhibitors for influenza: a systematic review and meta-analysis of regulatory and mortality data. Health Technol Assess. 2016 May;20(42):1-242. doi: 10.3310/hta20420. PMID: 27246259; PMCID: PMC4904189
  99. https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=1be5f2f3-9629-4399-afb3- 79567fc73f15&t=]
  100. Thorlund K, Awad T, Boivin G, Thabane L. Systematic review of influenza resistance to the neuraminidase inhibitors. BMC Infect Dis. 2011 May 19;11:134. doi: 10.1186/1471-2334- 11-134
  101. https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=8a669722-9591-4b7d-b91b- 4466fb275ad9&t=
  102. А.А. Баранов (ред.). Руководство по амбулаторно-клинической педиатрии. М. Гэотар- Медиа. 2-е изд. 2009.
  103. Feld LG, Neuspiel DR, Foster BA, Leu MG, Garber MD, Austin K, Basu RK, Conway EE Jr, Fehr JJ, Hawkins C, Kaplan RL, Rowe EV, Waseem M, Moritz ML; SUBCOMMITTEE ON FLUID AND ELECTROLYTE THERAPY. Clinical Practice Guideline: Maintenance Intravenous Fluids in Children. Pediatrics. 2018 Dec;142(6):e20183083.
  104. Duke T, Molyneux EM. Intravenous fluids for seriously ill children: time to reconsider. Lancet. 2003 Oct 18;362(9392):1320-3.
  105. https://www.uptodate.com/contents/pneumonia-in-children-inpatient-treatment? search=pneumonia%20acidosis&source=search_result&selectedTitle=2~150&usage_type=
  106. Ambroggio L, Test M, Metlay JP, Graf TR, Blosky MA, Macaluso M, Shah SS. Adjunct Systemic Corticosteroid Therapy in Children With Community-Acquired Pneumonia in the Outpatient Setting. J Pediatric Infect Dis Soc. 2015 Mar;4(1):21-7.
  107. Craig WA, Andes D. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. Pediatric Infectious Diseases Journal. 1996; 15:255–9.38..
  108. Chang CC, Cheng AC, Chang AB. Over-the-counter (OTC) medications to reduce cough as an adjunct to antibiotics for acute pneumonia in children and adults. Cochrane Database Syst Rev. 2014 Mar 10;(3):CD006088.
  109. Stern A, Skalsky K, Avni T, et al. Corticosteroids for pneumonia. Cochrane Database Syst Rev. 2017 Dec 13;12(12):CD007720.
  110. Tagarro A, Otheo E, Baquero-Artigao F, et al. Dexamethasone for parapneumonic pleural effusion: a randomized, double-blind, clinical trial. J Pediatr 2017; 185: 117–23.e6
  111. Das RR, Singh M, Naik SS. Vitamin D as an adjunct to antibiotics for the treatment of acute childhood pneumonia. Cochrane Database Syst Rev. 2018 Jul 19;7(7):CD011597.
  112. Hemilä H., Chalker E. Vitamin C for preventing and treating the common cold //Cochrane database of systematic reviews. – 2013. – №. 1
  113. Padhani Z. A. et al. Vitamin C supplementation for prevention and treatment of pneumonia //Cochrane Database of Systematic Reviews. – 2020. – №. 4
  114. Wu T., Ni J., Wei J. Vitamin A for non‐measles pneumonia in children //Cochrane Database of Systematic Reviews. – 2005. – №. 3
  115. Brown N., Roberts C. Vitamin A for acute respiratory infection in developing countries: a meta‐analysis //Acta Paediatrica. – 2004. – Т. 93. – №. 11. – С. 1437-144
  116. Kumar RM, Kabra SK, Singh M. Efficacy and acceptability of different modes of oxygen administration in children: implications for a community hospital. J Trop Pediatr 1997;43:47e9.
  117. Carter E, Waldhausen J, Zhang W, et al. Management of children with empyema: pleural drainage is not always necessary. Pediatr Pulmonol 2010; 45:475–80..
  118. Малявин А. Г., Епифанов В. А., Глазкова И. И. Реабилитация при заболеваниях органов дыхания.—М.: ГЭОТАР Медиа, 2010.–352 с.—(Библиотека врача специалиста). – 2010
  119. Swingler G. H., Michaels D., Hussey G. G. D. Conjugate vaccines for preventing Haemophilus influenzae type B infections //Cochrane Database of Systematic Reviews. – 2007. – №. 2
  120. The Green Book. Immunization against infections disease. 2013. Part 2, ch. 16. p. 127–143.
  121. Cox A.D., Barreto L., Ulanova M., et al. Developing a vaccine for Haemophilus influenzae serotype a. Canada communicable disease report. 2017; 43(5):89–95.
  122. Wiese A. D., Griffin M.R., Grijalva C.G Impact of pneumococcal conjugate vaccines on hospitalizations for pneumonia in the United States. Expert Rev Vaccines. 2019; 18(4): 327–341
  123. Lucero M. G. et al. Pneumococcal conjugate vaccines for preventing vaccine‐type invasive pneumococcal disease and X‐ray defined pneumonia in children less than two years of age //Cochrane database of systematic reviews. – 2009. – №. 4
  124. Sings H. L. et al. Effectiveness of 13-valent pneumococcal conjugate vaccine against invasive disease caused by serotype 3 in children: a systematic review and meta-analysis of observational studies //Clinical Infectious Diseases. – 2019. – Т. 68. – №. 12. – С. 2135- 2143
  125. Thompson A. et al. Safety of 13-valent pneumococcal conjugate vaccine in infants and children: meta-analysis of 13 clinical trials in 9 countries //Vaccine. – 2013. – Т. 31. – №. 45. – С. 5289-5295
  126. Ewald H. et al. The clinical effectiveness of pneumococcal conjugate vaccines: a systematic review and meta-analysis of randomized controlled trials //Deutsches Ärzteblatt International. – 2016. – Т. 113. – №. 9. – С. 139.
  127. Jones LL, Hashim A, McKeever T. Parental and household smoking and the increased risk of bronchitis, bronchiolitis and other lower respiratory infections in infancy: systematic review and meta-analysis. Respir Res. 2011;12(1):5.
  128. Watererl G., Bennett L. Improving Outcomes From Community-acquired Pneumonia. Curr Opin Pulm Med. 2015;21(3):219-225.
  129. Gattarello S, Borgatta B, Sole-Violan J, et al., Investigators CIs. Decrease in mortality in severe community-acquired pneumococcal pneumonia: impact of improving antibiotic strategies (2000–2013). Chest 2014; 146:22–31.0. Houck PM, Bratzler DW, Nsa W, et al. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med 2004; 164:637–644.

Для продолжения работы требуется Регистрация
На предыдущую страницу

Предыдущая страница

Следующая страница

На следующую страницу
Список литературы
На предыдущую главу Предыдущая глава
оглавление
Следующая глава На следующую главу